Not Yet RecruitingNot Applicable

A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eaton Myasthenic Syndrome (LEMS) in Subjects Diagnosed With Small Cell Lung Cancer (SCLC)

United States400 participantsStarted 2025-09

Plain-language summary

This is a multi-center observational study in subjects with a diagnosis of small cell lung cancer. Screening and/or medical record review for symptoms associated with Lambert Eaton Myasthenic Syndrome (LEMS) will be conducted.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult men or women meeting Age of Majority (AOM) at the time of consent
✓. Provide voluntary consent to participate in this study, documented via a signed informed Consent Form (ICF)
✓. Any diagnosis of SCLC
✓. Willing to provide clinical and medical information related to his/her cancer diagnoses to the study team as required
✓. Willing to comply with the requirements of the study

Exclusion criteria

✕. Has been diagnosed with non-tumor Lamber-Eaton Myasthenic syndrome (LEMS) \> 1 year prior to the SCLC diagnosis.
✕. Known existence of an uncontrolled intercurrent illness including, but not limited to, psychiatric illness or social situations that would impair compliance with study requirements

What they're measuring

Suspicious LEMS

Timeframe: 1 year

Trial details

NCT IDNCT07075627

SponsorAddario Lung Cancer Medical Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-09

Contact for this trial

Allison M Harper, PharmD

704-996-6579 aharper@alcmi.org

View on ClinicalTrials.gov More Small Cell Lung Cancer ( SCLC ) trials